Actual Medicinal Product (AMP) -
COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)
Name Details
|
Current Name
COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials
|
Start Date
10-05-2022
|
End Date
|
|
Previous Name
COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose suspension for injection multidose vials
|
Start Date
13-01-2022
|
End Date
09-05-2022
|
|
|
Abbreviated Name
COVID-19 Vaccine Vaxzevria 0.5ml inj multidose vials
|
Start Date
13-01-2022
|
|
| COVID-19 Vaccine AstraZeneca 0.5ml inj multidose vials |
Previous Start Date
30-11-2021
|
Previous End Date
12-01-2022
|
Summary
- Licensed Route
- Intramuscular
- Availability Restrictions
- Not available
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
| BNF |
|
Previous BNF
14040000
|
Start Date
22-10-2020
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 39114911000001105 |
22-10-2020 |
|
Actual Medicinal Product Pack (AMPP) Information